InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Harrell James Archie Jr, Directeur Commercial. Officer active across 3 companies, notably Cerecor Inc.. Cumulatively, 4 filings have been published. Total volume traded: €31k. The latest transaction was filed on 10 December 2021 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
€1,5191,093 shares@ €1.3902100.0% of flow
Common Stock
SEC:0001879785-21-000038·
Ideal exit: 6 Sept 2022 (T+270)
€1,5191,093 shares@ €1.39020.0005% mcap50.0% of flow
Common Stock
SEC:0001879785-21-000038:0·
Ideal exit: 6 Sept 2022 (T+270)
€14,0357,493 shares@ €1.8731100.0% of flow
Common Stock
SEC:0001192482-21-000499·
Ideal exit: 7 Mar 2022 (T+270)
€14,0357,493 shares@ €1.8731100.0% of flow
Common Stock
SEC:0001192482-21-000499:0·
Ideal exit: 7 Mar 2022 (T+270)
4 of 4 declarations
About Harrell James Archie Jr
James Archie Harrell Jr is the Chief Commercial Officer at Cerecor Inc. and Avalo Therapeutics, Inc. He is responsible for the commercial strategy and growth of these companies. James Archie Harrell Jr leverages his expertise to develop initiatives that strengthen Cerecor and Avalo's market position. His role is essential in supporting innovation and research in the healthcare field.
